Prevention by angiotensin II antiserum of drinking induced by intracranial angiotensin. 1973

A N Epstein, and J T Fitzsimons, and A K Johnson

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D008297 Male Males
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D002552 Cerebral Ventricles Four CSF-filled (see CEREBROSPINAL FLUID) cavities within the cerebral hemispheres (LATERAL VENTRICLES), in the midline (THIRD VENTRICLE) and within the PONS and MEDULLA OBLONGATA (FOURTH VENTRICLE). Foramen of Monro,Cerebral Ventricular System,Cerebral Ventricle,Cerebral Ventricular Systems,Monro Foramen,System, Cerebral Ventricular,Systems, Cerebral Ventricular,Ventricle, Cerebral,Ventricles, Cerebral,Ventricular System, Cerebral,Ventricular Systems, Cerebral
D004326 Drinking The consumption of liquids. Water Consumption,Water Intake,Drinkings
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

A N Epstein, and J T Fitzsimons, and A K Johnson
October 1980, Pharmacology, biochemistry, and behavior,
A N Epstein, and J T Fitzsimons, and A K Johnson
July 1979, The American journal of physiology,
A N Epstein, and J T Fitzsimons, and A K Johnson
April 1974, Canadian journal of physiology and pharmacology,
A N Epstein, and J T Fitzsimons, and A K Johnson
February 1983, General and comparative endocrinology,
A N Epstein, and J T Fitzsimons, and A K Johnson
October 1975, Science (New York, N.Y.),
A N Epstein, and J T Fitzsimons, and A K Johnson
February 2007, American journal of physiology. Heart and circulatory physiology,
A N Epstein, and J T Fitzsimons, and A K Johnson
October 1971, The Journal of physiology,
A N Epstein, and J T Fitzsimons, and A K Johnson
January 1984, Clinical and experimental hypertension. Part A, Theory and practice,
A N Epstein, and J T Fitzsimons, and A K Johnson
January 1987, Physiology & behavior,
A N Epstein, and J T Fitzsimons, and A K Johnson
January 1973, Pharmacology, biochemistry, and behavior,
Copied contents to your clipboard!